Valcyte and Normodyne drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valcyte (valganciclovir hydrochloride) and Normodyne (labetalol hydrochloride). Common drug interactions include asthenia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Valcyte and Normodyne. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.

What is Normodyne?

Normodyne has active ingredients of labetalol hydrochloride. eHealthMe is studying from 858 Normodyne users. Check the latest studies of Normodyne.



On Jul, 14, 2026

23 people who take Valcyte and Normodyne together, and have interactions are studied.

Valcyte and Normodyne drug interactions.

What are the common drug interactions of Valcyte and Normodyne, by gender? *:

female:

  1. Asthenia (weakness)
  2. Diarrhoea
  3. Lung infection
  4. Chronic kidney disease
  5. Cytomegalovirus infection
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Transplant rejection (a transplant material is not worked)

male:

  1. Anaemia (lack of blood)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Abdominal pain lower
  6. Gastroenteritis (inflammation of stomach and intestine)
  7. Nausea (feeling of having an urge to vomit)
  8. Vomiting
  9. Hip arthroplasty
  10. Hypoxia (low oxygen in tissues)

What are the common drug interactions of Valcyte and Normodyne, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Chronic kidney disease

20-29:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Haematuria (presence of blood in urine)
  3. Hypertension (high blood pressure)
  4. Kidney transplant rejection

30-39:

  1. Anaemia (lack of blood)
  2. Hip arthroplasty
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hypoxia (low oxygen in tissues)
  5. Leukopenia (less number of white blood cells in blood)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Weight bearing difficulty (difficulty due to weight of thigh fat deposition)
  8. Pulmonary oedema (fluid accumulation in the lungs)

40-49:

  1. Acute respiratory failure
  2. Anaemia (lack of blood)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Escherichia infection (bacterial infection by escherichia coli)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Ileus (a painful obstruction of the ileum or other part of the intestine)
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Pyelonephritis (inflammation of kidney caused by bacteria)
  10. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Chronic allograft nephropathy (failure of kidney transplant)
  2. Complications of transplanted kidney
  3. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  4. Haematocrit decreased
  5. Haemoglobin decreased
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Hypovolaemia (a decreased volume of circulating blood in the body)
  8. Kidney transplant rejection
  9. Nephrosclerosis (hardening of the kidney due to renovascular disease)
  10. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Perinephric collection (fluid collections surrounding a kidney)
  2. Renal artery stenosis (narrowing of renal artery)
  3. Transplant rejection (a transplant material is not worked)
  4. Duodenitis (inflammation of the duodenum)

What are the existing conditions these people have? *

  1. Immunodeficiency Disorders: 9 people, 39.13%
  2. Pain: 7 people, 30.43%
  3. High Blood Pressure: 6 people, 26.09%
  4. Indigestion: 4 people, 17.39%
  5. Sleep Disorder: 3 people, 13.04%
  6. Rickets (softening of bones): 3 people, 13.04%
  7. Kidney Transplant Rejection: 3 people, 13.04%
  8. Blood Magnesium Decreased: 3 people, 13.04%
  9. Type 2 Diabetes: 2 people, 8.70%
  10. Stress Gastritis (swelling (inflammation) and weakening of the stomach lining that occurs during a serious illness): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Valcyte and Normodyne?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valcyte and Normodyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valcyte:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Normodyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valcyte and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Normodyne and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on valganciclovir hydrochloride and labetalol hydrochloride (the active ingredients of Valcyte and Normodyne, respectively), and Valcyte and Normodyne (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: